BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 20096851)

  • 1. Progesterone receptor expression and proliferative activity in uterine tumours of pet rabbits.
    Vinci A; Bacci B; Benazzi C; Caldin M; Sarli G
    J Comp Pathol; 2010 May; 142(4):323-7. PubMed ID: 20096851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunohistochemical evaluation of estrogen receptor-alpha and progesterone receptors of normal, hyperplastic, and neoplastic endometrium in 88 pet rabbits.
    Asakawa MG; Goldschmidt MH; Une Y; Nomura Y
    Vet Pathol; 2008 Mar; 45(2):217-25. PubMed ID: 18424838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
    Ma XX; Zhang SL; Gao S; Lu JM; Dong F
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein.
    Walmer DK; Padin CJ; Wrona MA; Healy BE; Bentley RC; Tsao MS; Kohler MF; McLachlan JA; Gray KD
    Cancer Res; 1995 Mar; 55(5):1168-75. PubMed ID: 7867003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
    Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
    Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium.
    Arnett-Mansfield RL; deFazio A; Wain GV; Jaworski RC; Byth K; Mote PA; Clarke CL
    Cancer Res; 2001 Jun; 61(11):4576-82. PubMed ID: 11389093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
    Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
    Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
    Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
    Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer.
    Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N
    Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
    Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
    Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables.
    Kyushima N; Watanabe J; Hata H; Jobo T; Kameya T; Kuramoto H
    J Cancer Res Clin Oncol; 2002 Jun; 128(6):307-12. PubMed ID: 12073048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma.
    Miyamoto T; Watanabe J; Hata H; Jobo T; Kawaguchi M; Hattori M; Saito M; Kuramoto H
    J Steroid Biochem Mol Biol; 2004 Oct; 92(3):111-8. PubMed ID: 15555905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of fos and jun proto-oncogenes in benign versus malignant human uterine tissue.
    Nephew KP; Choi CM; Polek TC; McBride R; Bigsby RM; Khan SA; Husseinzadeh N
    Gynecol Oncol; 2000 Mar; 76(3):388-96. PubMed ID: 10684716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.
    Nishimura Y; Watanabe J; Jobo T; Kato N; Fujisawa T; Kamata Y; Kuramoto H
    Anticancer Res; 2004; 24(4):2185-91. PubMed ID: 15330159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
    Ozuysal S; Oztürk H; Bilgin T; Filiz G
    Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
    Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
    Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium.
    Arnett-Mansfield RL; DeFazio A; Mote PA; Clarke CL
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1429-42. PubMed ID: 15001645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium.
    Sonoda K; Kaku T; Hirakawa T; Kobayashi H; Amada S; Sakai K; Nakashima M; Watanabe T; Nakano H
    Gynecol Oncol; 2000 Dec; 79(3):424-9. PubMed ID: 11104614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.